According to this latest publication from Meticulous Research®, the Real-world Data (RWD) Market is expected to register a CAGR of 7.4% from 2022 to 2029 to reach $1.66 billion by 2029. The growing burden of chronic diseases, delays in drug development and the consequent increase in development costs, the rising attention toward personalized healthcare, the shift to value-based care, and rapidly growing big data in the healthcare sector are the major drivers for the real-world data (RWD) market. However, the lack of standardized methodologies for developing real-world data solutions is a major challenge for market growth.
Here are the top 10 companies operating in the Real-world Data (RWD) Market
Founded in 1982 and headquartered in North Carolina, U.S., IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry. In October 2016, Quintiles Transnational Holdings Inc. merged with IMS Health Holdings, Inc. and changed its name to Quintiles IMS Holdings, Inc. In November 2017, Quintiles IMS was renamed IQVIA to help healthcare stakeholders find clinical and analytical solutions for their patients through analytics and science. The company operates through three business segments: Technology & Analytics Solutions, Research & Development, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides critical information, technology, and real-world data solutions and services to life sciences clients providing access to deep clinical data in oncology, rare disease, and other specialty areas. The real-world insights provide post-approval/drug utilization studies and disease registries.
The company has a strong geographical presence across 82 countries through its 262 offices. The company offers its products to life sciences companies, including pharmaceutical, biotechnology, devices, diagnostic, and consumer health companies.
PPD Inc. (U.S.)
Founded in 1985 and headquartered in North Carolina, U.S., PPD provides integrated drug development, laboratory, and management lifecycle services to the biopharmaceutical industry. In December 2021, PPD Inc. was acquired by Thermo Fisher Scientific Inc. and became Thermo Fisher’s Laboratory Products and Services unit. The company operates through two business segments: Clinical Development Services and Laboratory Services. PPD provides real-world evidence solutions through its Peri and Post-approval Services subsegment (a part of the Clinical Development Services segment). This segment assists in advancing the drug development program and design protocol for post-approval and real-world patient observation, leading to new ideas and products. The company offers RWD services to pharmaceutical, biotechnology, and medical device companies and academic, government, and public health organizations.
The company has a geographical presence across the U.K., the U.S., Bulgaria, Mexico, Australia, China, India, and the Philippines and operates in the global real-world data market through its subsidiary Evidera (U.S.).
Incorporated in 1990 and headquartered in Dublin, Ireland, ICON provides consulting, clinical development, and commercialization services to pharmaceutical, biotechnology, and medical device companies and government and public health organizations. The company specializes in strategic development, management, analysis, and programs that support all clinical development stages, from compound selection to Phase I–IV clinical studies. Its offerings include clinical research, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real-world intelligence, and site & patient solutions. Additionally, the company provides services such as real-world evidence strategy & analytics, real-world evidence and late phase research, and direct-to-patient support through its real-world intelligence offering.
The company has a strong geographic presence across 41 countries, including Ireland, Australia, Japan, Russia, China, India, Canada, the U.S., Mexico, Brazil, Peru, Argentina, South Africa, Italy, Germany, France, the U.K., Turkey, Sweden, and Spain.
Parexel International Corporation (U.S.)
Incorporated in 1982 and headquartered in Massachusetts, U.S., Parexel is engaged in providing clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical devices industries worldwide. The company provides clinical research services, consulting, outsourcing services, medical communications, medical affairs, and real-world data sciences. The real-world data sciences segment provides services like business & strategy consulting, genomics/translational medicine, study optimization, patient & site recruitment and feasibility, patient safety/pharmacovigilance, real-world evidence generation, and market access planning.
The company has a geographical presence across the U.S., Mexico, Argentina, Brazil, Denmark, Czech Republic, Poland, the Netherlands, Belgium, Russia, Spain, France, Germany, U.K., Sweden, Switzerland, Australia, Korea, Singapore, India, Thailand, Indonesia, Japan, China, Malaysia, and the Middle East & Africa.
In June 2017, Parexel International Corporation was acquired by Pamplona Capital Management LLC. (U.S.) for USD 5 billion.
UnitedHealth Group Incorporated
The company offers services in more than 150 countries and has a strong geographical presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Meticulous Research in its latest publication on Real-world Data (RWD) Market has predicted the growth of 7.4% during the forecast year 2022-2029.
Flatiron Health, Inc. (U.S.)
The company has over 2,500 employees, including software engineers, data scientists, biostatisticians, epidemiologists, health professionals, and other experts.
Founded in 1977 and headquartered in California, U.S., Oracle provides products and services for corporate information technology (IT) environments through applications, platforms, and infrastructure. The company operates through three business segments, namely, Cloud License, Hardware, and Services. The Services segment provides solutions for the global real-world data market to maximize their investments in Oracle applications, platforms, and infrastructure technologies. The Oracle Health Sciences software offers real-world evidence solutions for clinical data managers, biostatisticians, and data scientists.
The company has a strong geographical presence across India, the U.S., Canada, Mexico, Argentina, Brazil, Peru, and Australia. Some of the company’s subsidiaries are Oracle Software Technology GmbH (Switzerland), Oracle Global Partners (Ireland), OCAPAC Holding Company UC (Ireland), OCAPAC research Partner UC (Ireland), Oracle EMEA Holdings Limited (Ireland), Oracle International Group Limited (Isle of Man), Oracle EMEA & CAPAC Holdings Limited (Bermuda), and Oracle International Holdings Limited (Bermuda).
As of May 2021, the company reported a global headcount of 132,000 full-time employees. Of these, approximately 45,000 were employed in the U.S. and 87,000 were employed internationally.
SAS Institute Inc. (U.S.)
Founded in 1976 and headquartered in North Carolina, U.S., SAS Institute provides analytics, business intelligence, and data management software & services. The company serves its solutions in automotive, banking, capital markets, casinos, communication, healthcare, health insurance, life sciences, and other end-use industries. In the real-world data market, the company offers end-to-end capabilities in data management, cohort extraction, and advanced analytics to generate clinical and scientific evidence. SAS offers its services in 147 countries and has a strong geographical presence across the U.S., Canada, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. Its software were installed at over 83,000 business, government, and university sites.
Elevance Health has a geographical presence across the U.S. and conducts business through its subsidiaries in over 25 states. Some of its subsidiaries are American Imaging Management, Inc. (U.S.), Aspire Health, Inc. (U.S.), and Beacon Health Options, Inc. (U.S.).
Clinigen Group plc (U.K.)
Established in 2008 and headquartered in Burton, U.K., Clinigen Group provides medicines. In April 2022, Clinigen Group was acquired by Triton Investment Management Limited. Clinigen Group operates in two business segments, namely, Products and Services. The Services segment offers real-world evidence solutions and services to capture anonymized data and gain unique insights into how patients are diagnosed and treated in a real-world setting.
The company has a strong geographical presence through sales, offices, and warehouses across the U.S., the U.K., Japan, Australia, New Zealand, South Africa, Belgium, Germany, France, and Switzerland.
Cognizant Technology Solutions Corporation (U.S.)
The company has a geographical presence across the U.S., the Philippines, Canada, Mexico, India, Australia, China, Japan, Singapore, Thailand, South Africa, Germany, the U.K., France, Italy, Spain, Sweden, Switzerland, the Netherlands, and Poland.
PerkinElmer, Inc. (U.S.)
Founded in 1937 and headquartered in Massachusetts, U.S., PerkinElmer provides products, services, and solutions for the diagnostics, food, environmental, industrial, life sciences research, and laboratory services markets. The company operates through two business segments, namely, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers products and services for end markets such as life sciences and applied markets, including industrial, environmental, and food markets. The company offers real-world evidence solutions through its discovery & analytical solutions to the life sciences market.
The company has a strong geographical presence across the U.S., China, U.K., Germany, India, Italy, France, and Japan and offers its products and services in more than 190 countries through a network of distributors to sell products in the regions where it does not have a sales and service presence. Some of its subsidiaries are Clinical & Analytical Service Solutions Ltd. (U.K.), PerkinElmer SAS (France), PerkinElmer (India) Pte Ltd., PerkinElmer Srl (Italy), PerkinElmer Japan Co. Ltd. (Japan), and PerkinElmer Technologies GmbH & Co. KG (Germany).
Authoritative Research on the Real-world Data (RWD) Market – Global Opportunity Analysis and Industry Forecast (2022-2029)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.